申请人:LABORATORIOS DEL DR. ESTEVE S.A.
公开号:US20190031615A1
公开(公告)日:2019-01-31
The present invention relates to 3-ethyl-3-phenylazepane derivatives having dual pharmacological activity towards both the sigma (σ) receptor and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.